Cytokinetics inc (CYTK)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Cash flows from operating activities:
Net loss

-39,405

-30,640

-29,573

-32,113

-29,366

-26,468

-22,017

-27,523

-30,281

-40,485

-32,357

-29,081

-25,867

7,157

33,362

-11,611

-12,455

-9,229

-8,849

-10,551

-8,872

8,443

-5,971

-8,374

-8,744

6,531

-12,588

-15,041

-12,619

Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash interest expense on liability related to sale of future royalties

5,706

5,533

5,321

5,064

4,819

4,741

4,559

4,338

4,129

4,074

3,918

3,729

2,307

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash equity-related expense

-

-

-

-

-

-

2,572

2,505

2,403

-

2,447

2,219

1,922

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Non-cash stock-based compensation expense

3,524

-

-

-

2,282

-

-

-

-

-

-

-

-

1,880

1,866

1,789

1,611

1,348

1,121

1,202

896

886

891

859

694

656

845

1,130

966

Depreciation and amortization of property and equipment

408

391

336

280

286

-320

268

618

673

-

-

-

-

-

-

170

170

151

146

147

145

137

126

122

105

88

101

120

124

Depreciation of property and equipment

-

-

-

-

-

-

-

-

-

-

450

439

421

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest receivable and amortization on investments

293

-1,004

-375

-675

-533

-440

-737

-596

96

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net gain on disposal of equipment

-

-

-

-

-

-

-

-

-

-15

0

0

82

19

-3

2

0

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense related to debt

1,724

-

291

333

183

-

-176

411

177

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense related to long-term debt

-

-

-

-

-

-

-

-

-

-

-

139

139

139

138

138

119

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

-2,459

-1,413

-2,417

4,828

1,934

-6,925

8,920

199

-1,075

-8,888

10,000

-909

885

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract assets

0

0

-575

-1,897

-2,082

8,383

-4,499

-5,826

-3,212

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract assets

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Related party accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-12

-

43

-965

-45,676

45,456

871

-1,797

2,111

4

0

-328

324

Prepaid and other assets

-949

2,117

1,479

-717

983

209

162

-782

-1,406

-147

-355

1,424

1,239

-215

-3,678

3,558

1,042

-830

211

299

716

-547

-205

418

60

-74

-288

228

-684

Operating lease right-of-use assets

-1,016

-921

-898

-877

-856

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-4,633

4,748

-1,782

2,647

-1,217

1,740

688

-1,087

-2,831

-5

3,350

-1,162

-726

3,032

-2,175

2,303

-1,462

139

305

216

95

-315

657

-407

-2,113

1,759

-31

728

-800

Accrued and other liabilities

-1,064

-265

1,320

-757

-2,466

46

-512

-2,664

1,067

898

3,780

-4,063

151

1,298

6,504

1,508

-365

1,654

759

2,000

-1,418

-636

-904

-765

-560

-1,639

3,204

2,061

-103

Contract liabilities

-

-

-

-

-

0

-8,132

-1,416

-9,202

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

-1,112

-1,022

-1,000

-938

-916

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-4,165

-7,841

-1,731

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract liabilities

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Related party payables and accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-150

Deferred revenue

-

-

-

-

-

-

-

-

-

-

2,434

-2,966

2,915

-3,073

11,299

-1,929

-4,095

-4,854

-3,574

-2,867

-1,447

28,264

-3,648

-2,184

-5,033

-

-

-

-

Net cash used in operating activities

-30,135

-19,055

-20,268

-24,677

-26,907

-12,327

-32,235

-26,846

-29,807

-24,071

-25,483

-31,261

-20,944

77,829

-12,122

-11,218

-17,507

-9,942

-10,347

-9,187

34,359

-8,130

-9,515

-9,376

-17,822

-12,429

10,309

6,624

-12,222

Cash flows from investing activities:
Purchases of investments

10,592

136,085

41,637

58,866

41,295

51,796

56,220

107,984

24,224

25,956

12,926

68,761

132,770

65,189

9,260

20,563

50,146

20,908

29,003

15,815

49,840

13,799

5,557

32,217

55,470

11,148

29,217

31,308

7,761

Sales and maturities of investments

55,122

32,125

56,325

56,149

61,196

78,500

59,255

63,856

44,621

57,499

53,035

45,070

21,858

24,073

23,536

16,631

30,405

46,522

40,362

27,429

17,877

20,350

15,724

41,081

26,943

17,203

21,694

21,139

18,408

Purchases of property and equipment

1,041

1,306

1,006

50

257

210

358

60

261

780

451

258

1,388

854

306

16

420

204

53

175

130

247

100

424

333

252

69

44

177

Net cash provided by investing activities

43,489

-105,266

13,682

-2,767

19,644

26,508

2,677

-44,188

20,136

30,763

39,658

-23,949

-112,300

-41,970

13,971

-3,916

-20,161

25,411

11,306

11,439

-32,093

6,304

10,067

8,440

-28,860

5,813

-7,592

-10,210

10,470

Cash flows from financing activities:
Proceeds from and payments for stock based award activities, net

2,162

-

-459

-989

701

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Claims settlement under Section 16(b)

2,151

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock under at-the-market offering, net of issuance costs

0

0

11,400

19,697

5,117

0

0

0

0

0

-8

94,877

17,355

0

0

0

0

-

-

-

-

9,102

0

0

39,869

-

-

-

-

Proceeds from common stock award exercise

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of future royalties, net of issuance costs

-

-

-

-

-

-

-

-

-

0

0

0

90,621

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock related to sale of future royalties, net of issuance costs

-

-

-

-

-

-

-

-

-

0

0

0

7,560

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from long-term debt, net of debt discount and issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

14,996

14,890

0

0

0

-

-

-

-

-

-

-

-

Issuance of equity for stock-based awards and warrants, net

-

-

-

-

-

-

-

-

524

-933

-1,442

-11,680

-198

-715

-727

-589

135

-82

-164

-41

-65

-32

0

-35

89

-7,516

483

0

-5

Net cash (used in) provided by financing activities

-11

121,120

11,859

22,396

4,416

451

10,227

2,978

-524

2,194

1,434

106,557

115,734

715

727

589

14,861

23,645

164

41

65

9,134

0

35

39,780

7,516

-516

7,483

5

Net increase (decrease) in cash and cash equivalents

13,343

-3,201

5,273

-5,048

-2,847

14,632

-19,331

-68,056

-10,195

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-17,510

36,574

2,576

-14,545

-22,807

39,114

1,123

2,293

2,331

7,308

552

-901

-6,902

900

2,201

3,897

-1,747

Non-cash investing and financing activities:
Right-of-use assets recognized in exchange for lease obligations

1,106

0

0

1

10,686

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-